Synthesize Bio secures $10M in a Seed round led by Madrona to enhance generative genomics for drug development.
Amount Raised
$10 Million
Round Type
Seed
SeattleBiotechnologyInvestors
Description
Synthesize Bio, a biotechnology firm, has announced a $10 million seed round led by Madrona, with participation from multiple investors. The funding aims to accelerate the development of its innovative generative genomics models. These models will assist biopharma companies in making informed drug development decisions. The GEM-1 foundation model is now available for use by biopharmaceutical companies and researchers.
Quick answer
Synthesize Bio raised $10 Million in a Seed round, dated September 17, 2025. Investors: AI2 Incubator, Sahsen Ventures, Inner Loop Capital, Point Field Partners and Madrona. Synthesize Bio is based in Seattle, Washington, United States.
- How much did Synthesize Bio raise?
- Synthesize Bio raised $10 Million in a Seed round on September 17, 2025.
- Who invested in Synthesize Bio?
- AI2 Incubator, Sahsen Ventures, Inner Loop Capital, Point Field Partners and Madrona are named as investors in this round.
- What does Synthesize Bio do?
- Synthesize Bio is a biotechnology company pioneering biological foundation models to simulate the results of gene expression experiments.
- Where is Synthesize Bio based and how big is it?
- Synthesize Bio is based in Seattle, Washington, United States. Fundz records about 16 employees.
- Who are the decision-makers at Synthesize Bio?
- Fundz holds 1 contact at Synthesize Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Synthesize Bio that raised within 45 days of this round, from Fundz verified event records.
- MyndTec raised $38K on October 31, 2025.
- Altrove raised $10M (Seed) on October 31, 2025.
- Creative Medical Technology Holdings raised $4.2M (Funding Round) on October 31, 2025.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- PACT raised $21M (Series A) on October 31, 2025.
- Zetagen Therapeutics raised $13M on October 31, 2025.
Who to call at Synthesize Bio, and when
A new round usually means Synthesize Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Synthesize Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Synthesize Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synthesize Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synthesize Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Synthesize Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.